Adaptive Computerized COPD Exacerbation Self-management Support (ACCESS): a randomized controlled trial.
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)10024970
- Registration Number
- NL-OMON42056
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 86
Inclusion Criteria
- age >= 40 years;
- confirmed diagnosis of COPD by spirometry (post-bronchodilator FEV1/FVC < 0.70);
- at least 2 self-reported exacerbations in the previous 12 months, i.e. a change for >= 2 consecutive days in either >= 2 major symptoms (dyspnea, sputum purulence, sputum amount) or any 1 major symptom plus any >= 1 minor symptoms (colds, wheeze, sore throat, cough)
Exclusion Criteria
- self-reported co-morbid conditions that prohibit participation;
- unable to communicate in the Dutch language;
- severe difficulties using a smartphone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary aim: to improve the number of exacerbation-free weeks. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary aims: to improve exacerbation self-management,<br /><br>exacerbation-management related self-efficacy, and quality of life. To decrease<br /><br>ER visits, hospital admissions and COPD related costs.</p><br>